A male animal can only produce a male clone, and vice versa – at least, that was the case until now. In a breakthrough they ...
CRISPR Therapeutics (NASDAQ: CRSP) is up only slightly more than 8% so far this year, well under the 27% return of the Nasdaq ...
Three fatalities occurring recently in China clinical trials have spurred two members of U.S. Congress to urge the FDA to ...
RNA therapies hold tremendous promise for treating genetic eye diseases. However, their development is limited by the lack of ...
Scribe Therapeutics’ one-time epigenetic treatment is designed to slash the adherence burden of chronic cholesterol-lowering ...
Scientists at a biotech company have used gene editing to switch off a gene that produces the main allergy-causing protein in ...
Agriculture has always evolved through better tools.
In people with type 1 diabetes, the immune system mistakenly destroys the pancreatic beta cells responsible for producing ...
California's bid to ban glow-in-the-dark rabbits and other designer pets stalls as gene-editing technology advances ...
In people with type 1 diabetes, the immune system mistakenly destroys the pancreatic beta cells responsible for producing ...
(NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results